STOCK TITAN

Scotts Miracle Gr SEC Filings

SMG NYSE

Welcome to our dedicated page for Scotts Miracle Gr SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Lawn lovers dissect Scotts Miracle-Gro’s fertilizer formulas; indoor cultivators parse Hawthorne hydroponic margins. Yet the financial story behind every bag of Miracle-Gro often hides inside dense disclosures. If you’ve searched “Scotts Miracle-Gro insider trading Form 4 transactions” or wondered how costs shift in a “Scotts Miracle-Gro quarterly earnings report 10-Q filing,” you know the challenge. Stock Titan solves it by delivering Scotts Miracle-Gro SEC filings explained simply, combining EDGAR speed with contextual AI.

Our platform ingests each submission the moment it posts to the SEC, then provides:

  • AI-powered summaries that translate legal language into clear takeaways
  • Real-time alerts for Scotts Miracle-Gro Form 4 insider transactions real-time
  • Side-by-side comparisons so understanding Scotts Miracle-Gro SEC documents with AI becomes second nature
  • Segment drill-downs linking hydroponic sales or fertilizer demand directly to the footnotes that matter

Whether you need Scotts Miracle-Gro earnings report filing analysis before the market opens, a Scotts Miracle-Gro annual report 10-K simplified for long-term forecasting, or a deep dive into Scotts Miracle-Gro proxy statement executive compensation, our coverage is exhaustive. We also flag every Scotts Miracle-Gro executive stock transactions Form 4 and keep you informed with Scotts Miracle-Gro 8-K material events explained. From seasonal fertilizer demand swings to evolving cannabis regulations, the insights investors rely on are only a click away.

Rhea-AI Summary

The Scotts Miracle-Gro Company director reports routine equity-based compensation activity. A company director filed a Form 4 disclosing the acquisition of 42 dividend equivalent rights tied to existing deferred stock units (DSUs) or restricted stock units (RSUs) on 12/05/2025. After this transaction, the reporting person holds 150 derivative securities directly. The filing explains that each dividend equivalent right is economically equal to one common share of Scotts Miracle-Gro and vests proportionately with the related DSUs or RSUs, reflecting ongoing alignment of director compensation with shareholder interests rather than a cash transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Scotts Miracle-Gro director reports dividend-equivalent award

A director of Scotts Miracle-Gro Co. reported a routine equity-related transaction involving derivative securities. On 12/05/2025, the reporting person acquired 187 dividend equivalent rights, recorded as an "A" (acquired) transaction. These rights are tied to existing deferred stock unit (DSU) or restricted stock unit (RSU) grants and become exercisable proportionately with the underlying DSUs or RSUs.

Each dividend equivalent right is described as the economic equivalent of one common share of Scotts Miracle-Gro. Following this transaction, the reporting person beneficially owned 1,210 derivative securities on a direct basis, reflecting ongoing participation in the company’s equity-based compensation programs rather than a change in control or role.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Scotts Miracle-Gro Chairman and CEO James Hagedorn, who is also a director and 10% owner, reported acquiring additional derivative equity in the form of phantom stock. On 12/05/2025, he received 2,751.65 shares of phantom stock, each representing the right to receive one common share of Scotts Miracle-Gro or the cash value of a share. Following this transaction, he beneficially owned 231,850.829 phantom stock units in total. These phantom stock shares are payable in cash after his employment with the company ends, and he may transfer the phantom stock into an alternative investment at any time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

The Scotts Miracle-Gro Company director reports routine equity-based compensation activity. A director of Scotts Miracle-Gro, identified in the signature block as Brian E. Sandoval, reported a transaction dated 12/05/2025 involving derivative securities tied to the company’s common shares. The filing shows the acquisition of 189 dividend equivalent rights related to existing deferred stock unit (DSU) or restricted stock unit (RSU) grants. Each dividend equivalent right is described as the economic equivalent of one common share of Scotts Miracle-Gro.

Following this transaction, the reporting person beneficially owns 1,154 derivative securities in direct form. According to the explanation, these dividend equivalent rights accrue on DSU or RSU grants and become exercisable proportionately with the underlying awards, aligning the director’s economic interests with those of common shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

The Scotts Miracle-Gro Company director Edith Aviles reported an equity-related transaction involving derivative securities. On 12/05/2025, she acquired 121 dividend equivalent rights tied to deferred stock units (DSUs) or restricted stock units (RSUs). Each dividend equivalent right is the economic equivalent of one common share of Scotts Miracle-Gro. Following this transaction, she held 783 derivative securities on a direct ownership basis. These awards track the value of common shares but are reported separately from standard stock holdings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Scotts Miracle-Gro Company executive Christopher J. Hagedorn, who serves as EVP & Chief of Staff, reported a small increase in his direct ownership of company stock. On 11/28/2025, he acquired 4.693 common shares of Scotts Miracle-Gro at a price of $46.24 per share in a non-open-market transaction coded "J."

Following this transaction, Hagedorn now beneficially owns 60,106.7964 common shares of Scotts Miracle-Gro, held directly. The filing was made as a Form 4 for a single reporting person, documenting his updated ownership position for investors and regulators.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

The Scotts Miracle-Gro Company Chairman and CEO James Hagedorn, who is also a director and more than 10% owner of SCOTTS MIRACLE-GRO CO (SMG), reported a small change in his holdings. On 11/28/2025, a transaction coded "J" added 43.253 common shares at a price of $46.24 per share to his directly held position.

After this transaction, Hagedorn beneficially owned 103,135.0688 common shares directly, plus 31,533.64 common shares held through a 401(k) plan and 997,910 common shares indirectly through Hagedorn Partnership, L.P., reflecting his proportionate and family-related interests. No derivative securities were reported in this filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

The Scotts Miracle-Gro Company executive reports small share acquisition

A senior executive of The Scotts Miracle-Gro Company, serving as EVP, CFO & CAO, reported a minor change in his holdings of the company’s common shares. On 11/28/2025, he acquired 3.244 common shares at a price of $46.24 per share, reported under transaction code J, which is used for other types of acquisitions or transfers. Following this transaction, he beneficially owned 15,282.749 common shares in a direct account and 493.482 common shares through a 401(k) plan. This filing reflects routine insider ownership reporting rather than a major corporate event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

The Scotts Miracle-Gro Company Chairman and CEO James Hagedorn reported a compensation-related transaction involving phantom stock tied to the company’s common shares. On 11/26/2025, he acquired 1,595.606 phantom stock units at a reference price of $56.61 per unit. Each phantom share represents the right to receive one common share of Scotts Miracle-Gro or the cash value of a share.

The phantom stock is payable in cash after his employment with the company ends, and he may transfer these units into an alternative investment at any time. Following this transaction, Hagedorn beneficially owned 229,099.179 derivative securities directly, reflecting his ongoing equity-linked stake in the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

The Scotts Miracle-Gro Company executive reports new phantom stock awards. Executive Vice President, Chief Financial Officer and Chief Administrative Officer Mark J. Scheiwer, a reporting person for Scotts Miracle-Gro (SMG), reported two acquisitions of phantom stock tied to the company’s common shares. On 11/17/2025, he acquired 72.09 phantom stock units at a derivative security price of $56.07, bringing his total derivative securities beneficially owned to 1,163.244 units. On 11/26/2025, he acquired an additional 10.046 phantom stock units at a derivative security price of $56.61, increasing his holdings to 1,173.29 phantom stock units.

Each phantom stock unit represents the right to receive one common share of Scotts Miracle-Gro or its cash value, and these phantom shares are payable in cash after the end of Scheiwer’s employment. He may transfer his phantom stock into an alternative investment at any time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Scotts Miracle Gr (SMG)?

The current stock price of Scotts Miracle Gr (SMG) is $57.81 as of December 25, 2025.

What is the market cap of Scotts Miracle Gr (SMG)?

The market cap of Scotts Miracle Gr (SMG) is approximately 3.4B.
Scotts Miracle Gr

NYSE:SMG

SMG Rankings

SMG Stock Data

3.35B
44.26M
23.82%
78.81%
6.41%
Agricultural Inputs
Agricultural Chemicals
Link
United States
MARYSVILLE